The global market for pharmaceuticals and medical devices continues to grow rapidly, and in response, manufacturers are moving to align their market strategy and product pipeline to meet emerging, unmet needs. Companies exploring opportunities in global markets face dynamic demographic and disease trends, changing market demands, and evolving regulatory requirements — all of which differ from one country to another. This complex environment makes planning for global market entry into both developed and developing countries a moving target.